Stuart Schreiber (L) and Magnet Biomedicine president and CSO Brian Safina

Stu­art Schreiber start­up launch­es with $50M to take mol­e­c­u­lar glue med­i­cines be­yond pro­tein degra­da­tion

Mag­net Bio­med­i­cine launched Tues­day morn­ing with $50 mil­lion in Se­ries A fi­nanc­ing to ex­pand the scope of mol­e­c­u­lar glues, drugs that link two pro­teins to­geth­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.